Maria Fitzgibbon
Papers
2
Total Citations
56
H-Index
2
About
Dr. Maria Fitzgibbon is a leading researcher in the field of inborn errors of metabolism, with a particular focus on classical galactosaemia. Her major contributions center on unraveling the molecular mechanisms underlying this rare genetic disorder, specifically through the lens of immunoglobulin G (IgG) N-glycosylation. Her seminal 2016 work, "Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis," which has garnered 46 citations, provided groundbreaking evidence that galactosaemia disrupts the normal biosynthesis of N-glycans, leading to aberrant IgG glycosylation patterns. This discovery not only deepened the understanding of the disease's pathophysiology but also opened new avenues for monitoring and potential therapeutic intervention. Building on this, her 2015 study introduced the use of IgG N-glycosylation galactose incorporation ratios as a novel biomarker for tracking disease status, a practical tool that has been cited 10 times. Dr. Fitzgibbon’s work bridges the gap between basic glycobiology and clinical application, offering hope for improved management of patients with classical galactosaemia. Her research is widely recognized for its innovative approach to a long-standing metabolic challenge.
Research Focus
Key Achievements
Top Papers
- 1
- 2